PMID- 21225233 OWN - NLM STAT- MEDLINE DCOM- 20110509 LR - 20211020 IS - 1791-2431 (Electronic) IS - 1021-335X (Print) IS - 1021-335X (Linking) VI - 25 IP - 3 DP - 2011 Mar TI - Molecular characterization of late stomal recurrence following total laryngectomy. PG - 669-76 LID - 10.3892/or.2011.1136 [doi] AB - The goal was to determine recurrent or second primary status for late stomal malignancies, 16 and 17 years post-total laryngectomy in two laryngeal squamous cell carcinoma (LSCC) patients, based on DNA methylation signatures and HPV typing. Adopting a literature review based definition of late stomal recurrences as new primaries at the site of the stoma or neopharynx occurring >5 years after total laryngectomy, we employed a multi-gene candidate approach to examine promoter methylation in 24 tumor suppressor genes and PCR-based assays for HPV status offered additional insights into whether the late stomal tumors post-total laryngectomy were related or not. The primary tumor for Patient 1 was negative for HPV but had aberrant hypermethylation of APC, MLH1 and BRCA1. The stomal biopsy 17-years later showed presence of HPV-16 without any methylated genes. In Patient 2, HPV-11 and promoter methylation of APC identified in the primary tumor was also observed in the stomal malignancy 16 years post-total laryngectomy. Additional information provided by molecular typing for HPV and methylation markers underscored Patient 1's and 2's late stomal presentation as most likely a second primary and recurrence, respectively. DNA methylation markers are particularly advantageous because DNA methylation is an early event in tumorigenesis, and the epigenetic modification, 5-methylcytosine, is a stable marker. Molecular marks to discern genetic heterogeneity or relatedness of stomal malignancies several years post-total laryngectomy can provide clues to their status as either second primaries or likely recurrences. Our results support the hypothesis that a subset of stomal recurrences after total laryngectomy represents second primary tumors. FAU - Stephen, Josena K AU - Stephen JK AD - Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, Detroit, MI 48202, USA. FAU - Symal, Mausumi AU - Symal M FAU - Chen, Kang Mei AU - Chen KM FAU - Ghanem, Tamer AU - Ghanem T FAU - Deeb, Robert AU - Deeb R FAU - Shah, Veena AU - Shah V FAU - Havard, Shaleta AU - Havard S FAU - Worsham, Maria J AU - Worsham MJ LA - eng GR - R01 DE015990/DE/NIDCR NIH HHS/United States GR - R01 DE 15990/DE/NIDCR NIH HHS/United States PT - Case Reports PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20110110 PL - Greece TA - Oncol Rep JT - Oncology reports JID - 9422756 SB - IM MH - Aged MH - Carcinoma, Squamous Cell/complications/*genetics/pathology/*surgery MH - DNA Methylation MH - Epigenomics MH - Gene Expression Profiling MH - Gene Expression Regulation, Neoplastic MH - Human papillomavirus 11/genetics/physiology MH - Human papillomavirus 16/genetics/physiology MH - Humans MH - Laryngeal Neoplasms/complications/*genetics/pathology/*surgery MH - Laryngectomy/adverse effects MH - Male MH - Middle Aged MH - Neoplasm Recurrence, Local/complications/*genetics/pathology MH - Neoplasms, Second Primary/complications/genetics/pathology MH - Papillomavirus Infections/complications/genetics/pathology MH - Surgical Stomas/*pathology PMC - PMC3718469 MID - NIHMS486601 EDAT- 2011/01/13 06:00 MHDA- 2011/05/10 06:00 PMCR- 2013/07/22 CRDT- 2011/01/13 06:00 PHST- 2010/09/24 00:00 [received] PHST- 2010/10/27 00:00 [accepted] PHST- 2011/01/13 06:00 [entrez] PHST- 2011/01/13 06:00 [pubmed] PHST- 2011/05/10 06:00 [medline] PHST- 2013/07/22 00:00 [pmc-release] AID - 10.3892/or.2011.1136 [doi] PST - ppublish SO - Oncol Rep. 2011 Mar;25(3):669-76. doi: 10.3892/or.2011.1136. Epub 2011 Jan 10.